Dr. Graubert has been associated with the Washington University School of Medicine in St. Louis as well as the Dana-Farber Cancer Institute at Harvard.
He's been an investigator on several clinical trials related to unrelated-donor transplants, including a
study of the use of Vidaza after transplants for MDS patients.